@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAgBrp1MOB44HIoHdiG2VzhOlm-pyZAsSvQmRYkoaqGFw> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAgBrp1MOB44HIoHdiG2VzhOlm-pyZAsSvQmRYkoaqGFw#> .
@prefix beldoc: <http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix schem: <http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names/> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  sub:_1 occursIn: species:9606 ;
    rdf:object schem:serum%20ketone%20body ;
    rdf:predicate belv:increases ;
    rdf:subject schem:serum%20glucose ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(SCHEM:\"serum glucose\") -> a(SCHEM:\"serum ketone body\")" .
}
sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_4 ;
    pav:version "1.4" .
  sub:_2 dce:identifier "Diabetic ketoacidosis, The Merck Manual" ;
    dce:title "Diabetic ketoacidosis, The Merck Manual" ;
    dce:type "Other" .
  sub:_3 prov:value " Diabetic Ketoacidosis Metabolic acidosis from the accumulation of ketones due to severely depressed insulin levels.  Diabetic ketoacidosis (DKA) results from grossly deficient insulin availability, causing a transition from glucose to lipid oxidation and metabolism (see below). In type I DM patients, DKA is commonly precipitated by a lapse in insulin treatment or by an acute infection, trauma, or infarction that makes usual insulin treatment inadequate. Although type II DM patients rarely have DKA, many may have ketone formation and acidosis (usually mild) because of a decrease in food intake and a marked decrease in insulin secretion due to severe and chronic hyperglycemia (glucose toxicity)." ;
    prov:wasQuotedFrom sub:_2 .
  sub:_4 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource sub:_2 ;
    prov:wasDerivedFrom beldoc: , sub:_3 .
}
sub:pubinfo {
  this: dct:created "2014-07-03T14:29:43.524+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}